Herantis Pharma Plc. logo

Herantis Pharma Plc. jobs and careers

About Herantis Pharma Plc.

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First North Growth Market Finland.

Founded in 2008 by Henri Huttunen.

Founded
2008
Employees
11 to 50
Total funding
$22.6M

Leadership

The top of Herantis Pharma Plc.'s org chart, with how many people report into each leader.

AV

Antti Vuolanto

CEO

5 reports

RNPhoto of Riikka Niemi

Riikka Niemi

IR Manager

1 report

KHPhoto of Kira Holmström

Kira Holmström

Head of Biomarker Research

AMPhoto of Ana Raquel Moreira

Ana Raquel Moreira

Head of Clinical Development

NK

Natalia Kulesskaya

Head of Nonclinical Pharmacology

Jobs at Herantis Pharma Plc.

No open positions right now. Explore more companies on TheJobsMap.